Kos J, Langiu M, Hellyer S, Gregory K
ACS Pharmacol Transl Sci. 2024; 7(12):3671-3690.
PMID: 39698283
PMC: 11651194.
DOI: 10.1021/acsptsci.4c00213.
Mansouri M, Kremser L, Nguyen T, Kasugai Y, Caberlotto L, Gassmann M
Cells. 2023; 12(9).
PMID: 37174725
PMC: 10177021.
DOI: 10.3390/cells12091325.
Eguchi K, Le Monnier E, Shigemoto R
J Neurosci. 2023; 43(23):4197-4216.
PMID: 37160366
PMC: 10255094.
DOI: 10.1523/JNEUROSCI.1514-22.2023.
Fabian C, Seney M, Joffe M
Int Rev Neurobiol. 2023; 168:311-347.
PMID: 36868632
PMC: 10392610.
DOI: 10.1016/bs.irn.2022.10.002.
Sakashita K, Nishida K, Takenaka Y, Yokota I, Yamasaki H, Nishimoto K
Case Rep Neurol. 2023; 14(3):494-500.
PMID: 36654530
PMC: 9841793.
DOI: 10.1159/000526632.
Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic.
Martin L, Adams D, Niedzwiecki M, Wong M
Cells. 2022; 11(21).
PMID: 36359844
PMC: 9657572.
DOI: 10.3390/cells11213448.
Group 1 metabotropic glutamate receptor 5 is involved in synaptically-induced Ca-spikes and cell death in cultured rat hippocampal neurons.
Yang J, Jeon S, Jang H, Yoon S
Korean J Physiol Pharmacol. 2022; 26(6):531-540.
PMID: 36302627
PMC: 9614404.
DOI: 10.4196/kjpp.2022.26.6.531.
Transcriptional regulation of NRF1 on metabotropic glutamate receptors in a neonatal hypoxic‑ischemic encephalopathy rat model.
Wang D, Xu M, Huang L, Wang X, Zhu L
Pediatr Res. 2022; 93(7):1865-1872.
PMID: 36280709
DOI: 10.1038/s41390-022-02353-9.
Group I mGluRs in Therapy and Diagnosis of Parkinson's Disease: Focus on mGluR5 Subtype.
Azam S, Jakaria M, Kim J, Ahn J, Kim I, Choi D
Biomedicines. 2022; 10(4).
PMID: 35453614
PMC: 9032558.
DOI: 10.3390/biomedicines10040864.
Group I Metabotropic Glutamate Receptors and Interacting Partners: An Update.
Mao L, Bodepudi A, Chu X, Wang J
Int J Mol Sci. 2022; 23(2).
PMID: 35055030
PMC: 8778124.
DOI: 10.3390/ijms23020840.
The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer's Disease.
de Lima I, Ribeiro F
Curr Neuropharmacol. 2021; 21(2):164-182.
PMID: 34951388
PMC: 10190153.
DOI: 10.2174/1570159X20666211223140303.
Unraveling the Role of Dopaminergic and Calretinin Interneurons in the Olfactory Bulb.
Capsoni S, Fogli Iseppe A, Casciano F, Pignatelli A
Front Neural Circuits. 2021; 15:718221.
PMID: 34690707
PMC: 8531203.
DOI: 10.3389/fncir.2021.718221.
Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective.
Su L, Wang N, Han J, Shen Y
Neuroscientist. 2021; 28(5):453-468.
PMID: 34088252
PMC: 9449437.
DOI: 10.1177/10738584211021018.
Hypergravity induced disruption of cerebellar motor coordination.
Noh W, Lee M, Kim H, Kim K, Yang S
Sci Rep. 2020; 10(1):4452.
PMID: 32157179
PMC: 7064588.
DOI: 10.1038/s41598-020-61453-w.
DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations.
Kim B, Jeong Y, Wong M, Martin L
Acta Neuropathol Commun. 2020; 8(1):7.
PMID: 32005289
PMC: 6995159.
DOI: 10.1186/s40478-019-0874-4.
Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature.
Christ M, Muller T, Bien C, Hagen T, Naumann M, Bayas A
Ther Adv Neurol Disord. 2019; 12:1756286419847418.
PMID: 31205493
PMC: 6535747.
DOI: 10.1177/1756286419847418.
Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using C-ITMM positron emission tomography.
Ishibashi K, Miura Y, Toyohara J, Ishiwata K, Ishii K
Neuroimage Clin. 2019; 22:101783.
PMID: 30909027
PMC: 6434168.
DOI: 10.1016/j.nicl.2019.101783.
Anatomy and Physiology of Metabotropic Glutamate Receptors in Mammalian and Avian Auditory System.
Tang Z, Lu Y
HSOA Trends Anat Physiol. 2019; 1.
PMID: 30854519
PMC: 6405216.
DOI: 10.24966/TAP-7752/100001.
Role of Metabotropic Glutamate Receptors in Neurological Disorders.
Crupi R, Impellizzeri D, Cuzzocrea S
Front Mol Neurosci. 2019; 12:20.
PMID: 30800054
PMC: 6375857.
DOI: 10.3389/fnmol.2019.00020.
Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease.
Masilamoni G, Smith Y
Curr Opin Pharmacol. 2018; 38:72-80.
PMID: 29605730
PMC: 5949090.
DOI: 10.1016/j.coph.2018.03.004.